Trizepatide

Tirzepatide is a weight loss and type 2 diabetes medication. It is both a Glucose Dependent Insulinotropic Polypeptide(GIP) and a Glucagon-like Peptide 1(GLP-1) receptor agonist medication. Tirzepatide is the first drug of its kind providing dual GIP and GLP-1 properties making it unique to a suddenly crowded weight loss medication market. Tirzepatide is currently showing amazing weight loss results in clinical trials and clinical practice.
How does Tirzepatide support weight loss?
Tirzepatide slows down how food is metabolized by the body this in turn makes people feel fuller for longer which aids in body weight reduction. Trizepatide is different than other Medical Weight Loss solutions because it is the combination of two classes of medications. Trizepatide mimics both of the receptor agonists GIP and GLP-1 after food intake which alerts the pancreas to stop releasing insulin and sends a signal to the liver to decrease glucose levels. These signals help you feel fuller longer, slows digestion and aids glycemic control all leading to weight loss. A recent clinical trial of over 2,500 people split into two treatment groups, people taking Tirzepatide and people in a placebo group showed a weight loss of 15 to 20% of their starting body weight when using Tirzepatide for 72 weeks while the placebo group only showed 3% weight loss during that period. Tirzepatide appears to be the new leader in the recently active medical weight loss drug class.